To compare the efficacy and safety of oral dexamethasone and mycophenolate mofetil in the treatment of active vitiligo.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Actively progressive non-segmental vitiligo
- Registration Number
- CTRI/2018/02/011664
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Active progressive non-segmental vitiligo
Exclusion Criteria
•Age < 18 years.
•Leucoderma secondary to other causes
•Pregnancy/Lactation
•Patients with severe hepatic, renal or other systemic disorder
•Pre existing malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in VIDA scoringTimepoint: Reduction in VIDA scoring
- Secondary Outcome Measures
Name Time Method improvement in VASI, Investigators assessment scores and patients assessment scores, and degree of colour match in repigmentation achieved.Timepoint: fortnightly for 2 months, thereafter, monthly till completion of follow-up.